SPPL2B Antikörper (N-Term)
-
- Target Alle SPPL2B Antikörper anzeigen
- SPPL2B (Signal Peptide Peptidase-Like 2B (SPPL2B))
-
Bindungsspezifität
- N-Term
- Reaktivität
- Human, Ratte, Rind (Kuh), Maus, Schwein, Pferd, Hund, Meerschweinchen
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser SPPL2B Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC)
- Sequenz
- VARGNCTFYE KVRLAQGSGA RGLLIVSRER LVPPGGNKTQ YDEIGIPVAL
- Homologie
- Cow: 86%, Dog: 86%, Guinea Pig: 79%, Horse: 86%, Human: 100%, Mouse: 86%, Pig: 86%, Rat: 86%
- Produktmerkmale
- This is a rabbit polyclonal antibody against SPPL2B. It was validated on Western Blot and immunohistochemistry.
- Aufreinigung
- Affinity Purified
- Immunogen
- The immunogen is a synthetic peptide directed towards the N terminal region of human SPPL2B
- Top Product
- Discover our top product SPPL2B Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilutions should be determined experimentally by the investigator.
- Kommentare
-
Antigen size: 511 AA
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
BRI2-BRICHOS is increased in human amyloid plaques in early stages of Alzheimer's disease." in: Neurobiology of aging, Vol. 35, Issue 7, pp. 1596-604, (2014) (PubMed).
: "
-
BRI2-BRICHOS is increased in human amyloid plaques in early stages of Alzheimer's disease." in: Neurobiology of aging, Vol. 35, Issue 7, pp. 1596-604, (2014) (PubMed).
-
- Target
- SPPL2B (Signal Peptide Peptidase-Like 2B (SPPL2B))
- Andere Bezeichnung
- SPPL2B (SPPL2B Produkte)
- Synonyme
- SPPL2B antikoerper, wu:fc16e01 antikoerper, wu:fc85d12 antikoerper, zgc:136525 antikoerper, MGC147524 antikoerper, IMP-4 antikoerper, IMP4 antikoerper, PSH4 antikoerper, PSL1 antikoerper, 3110056O03Rik antikoerper, AW550292 antikoerper, RGD1308556 antikoerper, signal peptide peptidase-like 2 antikoerper, signal peptide peptidase like 2B antikoerper, signal peptide peptidase like 2B S homeolog antikoerper, signal peptide peptidase-like 2B antikoerper, sppl2 antikoerper, sppl2b antikoerper, sppl2b.S antikoerper, SPPL2B antikoerper, Sppl2b antikoerper
- Hintergrund
-
SPPL2B is a member of the GXGD family of aspartic proteases. The GXGD proteases are transmembrane proteins with two conserved catalytic motifs localized within the membrane-spanning regions. This enzyme localizes to endosomes, lysosomes, and the plasma membrane. It cleaves the transmembrane domain of tumor necrosis factor alpha to release the intracellular domain, which triggers cytokine expression in the innate and adaptive immunity pathways.
Alias Symbols: IMP4, KIAA1532, MGC111084, PSL1, IMP-4
Protein Size: 511 - Molekulargewicht
- 56 kDa
- Gen-ID
- 56928
- NCBI Accession
- NM_001077238, NP_001070706
-